Envista Holdings Corporation Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2019; Provides Earnings Guidance for the Full Year 2020
January 31, 2020 at 02:35 am IST
Share
Envista Holdings Corporation reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2019. For the quarter, sales were $720.5 million against $759.0 million reported a year ago. Operating profit were $78.0 million against $67.6 million reported a year ago. Net income were $56.1 million against $51.2 million reported a year ago. Basic net earnings per share was $0.35 against $0.40 reported a year ago.
For the full year, sales were $2,751.6 million against $2,844.5 million reported a year ago. Operating profit were $277.5 million against $298.4 million reported a year ago. Net income was $217.6 million against $230.7 million reported a year ago. Basic net earnings per share was $1.60 against $1.80 reported a year ago.
For the full year 2020, the company anticipates that earnings per share will be in the range of $1.21 to $1.31.
Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.
Envista Holdings Corporation Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2019; Provides Earnings Guidance for the Full Year 2020